ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2016 American Transplant Congress

    Pulse Wave Velocity Amongst African-American Kidney Transplant Recipients Randomized to Once-Daily MeltDose Tacrolimus Tablets (Envarsus XR) vs. Traditional Twice-Daily Tacrolimus Capsules: Exploratory Results from a Phase III Trial.

    J. Trofe-Clark,1,2 R. Townsend,2 R. Neubauer,2 M. Lim,2 L. Callahan,3 R. Bloom.2

    1Pharmacy Services, Hospital of the University of Pennsylvania, Philadelphia, PA; 2Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; 3Veloxis Pharmaceuticals, Edison, NJ.

    Cardiovascular (CV) death is a leading cause of death in kidney transplant recipients (KTR). Increased aortic arterial stiffness is strongly associated with the development of…
  • 2016 American Transplant Congress

    Therapeutically Equivalent Results to Caucasians in Black Kidney Transplant Recipients Using ASTAGRAF XL® Despite a Higher Degree of HLA Mismatch : A Post-Hoc Analysis of Phase III Data from Over 2000 Patients.

    J. Schwartz, S. Wilson, F. Shi, N. Undre, M. Kumar.

    Astelleas Pharma Global Develepment, Northbrook, IL.

    INTRO: When contemplating the use of a new immunosuppressant agent in kidney transplantation, measuring outcomes in potentially vulnerable populations is of paramount concern. As such,…
  • 2016 American Transplant Congress

    Determinants of 1 Year Graft Loss After Pre Kidney Transplant Bariatric Surgery.

    G. Mour, J. Zhang, Z. Su, D. Taber, P. Mauldin, T. Srinivas.

    Medical Unversity of South Carolina, Charleston, SC.

    Background: Bariatric surgery (BS) is increasingly used to manage weight pre-transplantation (Pre-Tx). However, grafts may be compromised by variable drug absorption, rejection and oxalate nephropathy.…
  • 2016 American Transplant Congress

    The UK ONE Study: Safety and Feasibility of Regulatory T Cell Therapy in Renal Transplantation.

    A. Bushell,1 J. van der Net,1,2 D. Game,3 R. Hilton,3 S. Thirkell,4 P. Friend,2 E. Geissler,5 K. Wood,1 P. Harden,2 G. Lombardi.4

    1Transplantation Research Immunology Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom; 2Oxford Transplant Centre, Oxford, United Kingdom; 3Guy's Hospital, London, United Kingdom; 4Immunoregulation Laboratory, King's College London, Guy's Hospital, London, United Kingdom; 5Department of Surgery, University Hospital Regensburg, Regensburg, Germany.

    Introduction: The UK ONE Study trial investigates the safety and feasibility of regulatory T (Treg) cell therapy in renal transplantation.Materials and Methods: Eleven (9m;2f) living…
  • 2016 American Transplant Congress

    Serial Peripheral Blood Mononuclear Cell Expression Profiling Reveals Inflammatory Genomic Storm Following Mechanical Circulatory Support Surgery.

    G. Godoy,1 G. Bondar,1 A. Esmaeili,1 E. Arellano,1 E. Chang,1 M. Bakir,1 J. Chittoor,1 R. Togashi,1 N. Fazli,1 C. Starling,1 E. Oh,1 S. Toluie,1 Z. Yang,2 D. Tran,1 M. Cadeiras,1 N. Wisniewski,1 M. Kwon,1 J. Schaenman,1 Y. Korin,1 M. Rosetti,1 E. Reed,1 M. Deng.1

    1University of California, Los Angeles, Los Angeles, CA; 2Shanxi Medical University First Hospital, Taiyuan, Shanxi, China.

    Introduction: The main cause of death in patients with Advanced Heart Failure (AdHF) is the Multi-Organ Dysfunction (MOD) Syndrome. Immune system aberrancy after Mechanical Circulatory…
  • 2016 American Transplant Congress

    A P2X7R Mutation with Hypermetabolic T Cells, Th1/Th17 Skewing and Reduced Cardiac Allograft Survival.

    F. D'Addio,1,2 A. Vergani,3 L. Potena,4 A. Maestroni,2 S. Tezza,1 M. Ben Nasr,1 V. Usuelli,2 M. Sbolli,1 L. Borgese,4 A. Iacovoni,5 D. Corradi,6 R. Abdi,7 A. Secchi,2 R. Starling,8 M. Sayegh,7,9 W. Harmon,1 D. Briscoe,1 P. Heeger,10 A. Chandraker,7 F. Grigioni,4 P. Fiorina.1,2

    1Boston Children's Hospital, Boston, MA; 2Ospedale San Raffaele, Milan, Italy; 3Dompe Research, Milan, Italy; 4University of Bologna, Bologna, Italy; 5Ospedale Papa Giovanni XXIII, Bergamo, Italy; 6University of Parma, Parma, Italy; 7Brigham and Women's Hospital, Boston; 8Cleveland Clinic, Cleveland; 9American University of Beirut, Lebanon, Lebanon; 10Icahn School of Medicine at Mount Sinai, New York.

    Background. The purinergic receptor-7 (P2X7R), primarily expressed on lymphocytes, senses ATP released extracellularly during cell damage and regulates T cell activation.Methods. In 640 heart transplant…
  • 2016 American Transplant Congress

    Natural Killer CD16/FcR Profiles May Associate with Enhanced Humoral Responsiveness in Heart Transplant Recipients with Cardiac Allograft Vasculopathy.

    P. Paul,1,2 C. Picard,3,4 E. Sampol,5 L. Lyonnet,1 J. Di Cristofaro,3,4 G. Lano,6, B. Dussol,6, F. Collart,7 F. Sabatier,1,2 F. Dignat George,1,2 A. Mouly Bandini.7

    1Hematology, Assistance Publique-Hopitaux Marseille (AP-HM), Marseille, France; 2UMR-1076, Aix Marseille Université (AMU), INSERM, Marseille, France; 3Établissement Français du Sang, Marseille, France; 4UMR7268, AMU, CNRS, Marseille, France; 5Pharmacokinetics, AP-HM, Marseille, France; 6Center for Clinical Investigation, AP-HM, Marseille, France; 7Cardiac Surgery, AP-HM, Marseille, France.

    Natural Killer cells (NK) are immune effectors of antibody-dependent cellular cytotoxicity (ADCC). Their role in mediating adverse effects of Donor-specific anti-HLA antibodies (DSA) towards cardiac…
  • 2016 American Transplant Congress

    Primary Graft Failure following Cardiac Transplantation Is Associated with Elevated Pre-Transplant Levels of Pro-Inflammatory Factors.

    D. Chatterjee,1 K. Clerkin,1 K. Rogers,1 D. Mancini,1 Y. Naka,1 H. Takayama,2 K. Takeda,2 P. Colombo,2 G. Vlad,3 R. Vasilescu,3 B. Levin,4 M. Farr,1 S. Restaino,1 E. Zorn.1

    1Columbia University Medical Center, NY; 2Surgery, Columbia University Medical Center, NY; 3Pathology & Cell Biology, Columbia University Medical Center, NY; 4Biostatistics, Columbia University Medical Center, NY.

    Primary graft failure (PGF) is defined as severe ventricular dysfunction immediately following heart transplantation (HTx) requiring temporary mechanical circulatory support (MCS) such as VA ECMO…
  • 2016 American Transplant Congress

    A New Diagnostic Score for Microvascular Inflammation in Antibody-Mediated Rejection in Heart Transplantation.

    M. Racapé,1 A. Loupy,2 R. Guillemain,1 A. François,3 P. Rouvier,4 C. Toquet,5 X. Jouven,1 J. Venner,6 L. Hidalgo,6 J. Reeve,6 P. Bruneval,1 J. Duong Van Huyen,2 P. Halloran.2

    1European Georges Pompidou Hospital, Paris, France; 2Necker Hospital, Paris, France; 3Rouen University Hospital, Rouen, France; 4La Pitié Salpêtrière Hospital, Paris, France; 5Laennec Hospital, Nantes, France; 6University of Alberta, Edmonton, Canada.

    BackgroundThe ISHLT working formulation defines Intravascular Activated Mononuclear Cells (IAMC) as one of the histopathologic features of antibody-mediated rejection (ABMR) in heart transplantation. However, no…
  • 2016 American Transplant Congress

    Donor-Specific Antibody Is a Major Independent Predictor of Accelerated Heart Allograft Vasculopathy (CAV).

    M. Bories,1 S. Varnous,2 C. Lefaucheur,3 P. Rouvier,2 R. Guillemain,1 P. Bruneval,1 J. Duong Van Huyen,4 A. Loupy.4

    1European Georges Pompidou Hospital, Paris, France; 2La Pitié Salpêtrière Hospital, Paris, France; 3Saint-Louis Hospital, Paris, France; 4Necker Hospital, Paris, France.

    Introduction The role of circulating DSA in addition to traditional cardiovascular risk factors, in the development of accelerated CAV have not been demonstrated. We investigated…
  • « Previous Page
  • 1
  • …
  • 1293
  • 1294
  • 1295
  • 1296
  • 1297
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences